Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy

Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy

ATLANTA, Nov. 17, 2020 /PRNewswire/ — UCB, a global pharmaceutical company, today announced th...
read more
CureVac’s COVID-19 Vaccine Candidate, CVnCoV, Suitable for Standard Fridge Temperature Logistics

CureVac’s COVID-19 Vaccine Candidate, CVnCoV, Suitable for Standard Fridge Temperature Logistics

TÜBINGEN, Germany / BOSTON, USA – Novem...
read more
Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease

Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease

CAMBRIDGE, Mass. and TOKYO, Nov. 06, 2020 (GLOBE N...
read more
Pfizer Canada and BioNTech Initiate Rolling Submission to Health Canada for SARS-CoV-2 Vaccine Candidate BNT162b2

Pfizer Canada and BioNTech Initiate Rolling Submission to Health Canada for SARS-CoV-2 Vaccine Candidate BNT162b2

KIRKLAND, QUEBEC, CANADA and MAINZ, GERMANY, Octob...
read more
Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy PF-06939926

Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy PF-06939926

NEW YORK–(BUSINESS WIRE)–October 01, 2...
read more
Telix Pharmaceuticals Submits New Drug Application to US FDA for Prostate Cancer Imaging Product

Telix Pharmaceuticals Submits New Drug Application to US FDA for Prostate Cancer Imaging Product

MELBOURNE, Australia and INDIANAPOLIS, Sept. 24, 2...
read more
FDA Approves Twirla

FDA Approves Twirla

FDA Approves Twirla (levonorgestrel and ethinyl es...
read more
FDA Approves Pemfexy

FDA Approves Pemfexy

FDA Approves Pemfexy (pemetrexed for injection) as...
read more
FDA Approves Audenz

FDA Approves Audenz

FDA Approves Audenz (Influenza A (H5N1) Monovalent...
read more
BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

Dabrafenib (Tafinlar), a BRAF inhibitor approved t...
read more
1 2 3 5